Background: Relatively few studies have focused on the validation of psychometric scales
Introduction
Antenatal major depressive disorder is a major health problem with a prevalence ranging from 3.1-4.9%. Taken together with the minor forms of the illness the point prevalence rises to 8.5-11.0% during pregnancy (Gaynes et al., 2005 , Kuijpens et al., 2001 ).
It is therefore essential that we have a tool to detect this illness effectively in those at risk. The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-rating scale, was developed by Cox et al. in 1987 , originally to detect postnatal depression (Cox et al., 1987) . The EPDS was constructed from the Snaith's Irritability, Depression and Anxiety Scale (Snaith et al., 1978) and the Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983 ) in addition to items formulated by the constructors (Cox et al., 1987 ).
Antenatal depression (AND) often remains unnoticed by health professionals, although it could be detected using self-report scales which are economical and do not require extensive rater training. The EPDS is the most widely used screening instrument perinatally, and it has also been validated in a non-gestational context showing good psychometric properties amongst men (Matthey et al., 2001 ), infertile women (Peterson et al., 2006) , in the perimenopausal period (Becht et al., 2001) , and in women who were not pregnant, apart from its original context, post partum (Cox et al., 1996) . Without trying to be exhaustive, the question as to whether the EPDS is a uni-or multidimensional scale has also been studied in both perinatal and non-gestational contexts with Pop et al (1992) (Thombs et al., 2014) , there is enough evidence to suggest that maternal depression is linked to poor maternal and infant health outcomes that argues in favour of improving routine screening during pregnancy.
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Early screening for antenatal depression is recommended by some national professional bodies, such as the UK's National Institute for Health and Clinical Excellence (NICE 2007) ("Antenatal and postnatal mental health: clinical management and service guidance"). Therefore, there is a well-defined and expressed need for an easy-to-administer self-report scale that can be used by healthcare professionals, such as midwives, obstetricians, health visitors, and family doctors.
There is a disagreement around whether pregnancy is a risk or a protective factor for mood disorders (Bergink et Investigators using the EPDS to screen for depression should realize that the instrument does not exclusively measure depression but anxiety too (Brouwers et al., 2001 , Matthey et al., 2013 . This, however, is more of an added benefit rather than a problem, as anxiety disorders, when discovered, can also be effectively treated.
A large review study (Gibson et 
Aims of the Study
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The primary objective of this study was to identify all published antenatal validation studies on the EPDS and to present their design along with the estimated sensitivity, specificity and positive and negative predictive values. An additional aim was to estimate the 95% confidence intervals of the screening values on the basis of the sample sizes and detected depression cases in each study. In addition, we assessed the association between the prevalence of antenatal depression and the estimates of the positive and negative predictive values of the Edinburgh Postnatal Depression Scale and the interrelation between the true and false positive rates of validation studies.
Methods
Search strategy
Previous validation studies of the EPDS during pregnancy in the English-language 
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Data quality
The quality of the selected studies was assessed using a grading system based on the York CRD system (Khan et al., 2001 ). Each study was assigned a grade on the basis of whether the clinicians were appropriately blinded to the EPDS scores, what reference standards were used for diagnosis and the sampling method used.
Data analysis
We tabulated the extracted data and analyzed the screening properties of EPDS for antenatal depression. With the exception of one study (Bergink et al., 2011) , relatively small numbers of women were included in the validation studies identified. Also, the studies aimed at choosing a cut-off score that allowed the highest sensitivity value without compromising too much on specificity (Krzanowski and Hand, 2009 ). The Wilson score method was used for presenting confidence intervals, because diagnosis is a binary variable and leads to a binomial distribution of the EPDS scores (Wallis, 2013) . 
Results
Search results
The search strategy identified 11 EPDS validation studies in the antenatal period 
Study sample/selection
The size of the study sample varied between 60 and 845 women interviewed. In the validation study by Murray and Cox (Murray and Cox, 1990) , available mothers were recruited ad hoc by a health care provider and they completed the EPDS before the interview. 
Diagnostic criteria
In an earlier validation study (Murray & Cox, 1990) , the EPDS was validated against the Research Diagnostic Criteria (RDC) set for depression, distinguishing between major, minor and intermittent depressive disorder (Spitzer et al., 1975; Spitzer et al., 1978) . In most Table 1 ). The overall point prevalence of major and combined depression extracted from the validation studies was 5.23% and 11.37%, respectively (not presented in the Tables).
Diagnostic instruments
In all studies, the validation was performed with a clinical interview. In order to establish the diagnosis of major/minor depression, three studies ( Table 2 
Quality assessment
Sensitivity and specificity
The estimates of sensitivity of the EPDS between studies varied from 70% to 100% for major depression and from 64 to 87% for combined depression. There was also a large variation in specificity from 74% to 97% and from 73% to 96% for major and combined depression, respectively (Table 1) . Studies with higher cut-off score for major depression did not always produce lower sensitivity and higher specificity than studies with a lower cut-off, likely reflecting cultural differences. Studies in which a high EPDS cut-off score for (Table 1) .
Confidence intervals
Confidence intervals of the sensitivity and specificity estimates of the EPDS were not presented in any of the validation studies and could not be calculated in one study (Wang et al., 2009). Our estimates of the 95% confidence intervals for the sensitivity and specificity in each study are presented in Table 1 . Sensitivity and specificity values were higher and the confidence intervals narrower for major depression compared to combined depression.
Confidence intervals were narrower for specificity than for sensitivity values. Studies that had narrower confidence intervals for sensitivity ( 
Positive and negative predictive values
The positive and negative predictive values (PPVs and NPVs) with confidence intervals of the EPDS total scores for the detection of depression for each validation study are presented in Table 3 , except for the Chinese validation (Wang et al., 2009 ) where they could not be calculated. PPVs ranged between 22% and 75%, whereas NPVs from 92% to 100%.
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Higher predictive values can be observed at a higher prevalence of antenatal depression. We also calculated estimates of these values based on the sensitivity and specificity values published in a studies on combined depression, assuming prevalences of 7.4%, 12.8% and 12.0% of combined depression in the first, second and third trimester, respectively, based on Figure 2 shows the impact of prevalence on negative predictive value. Figure 3 depicts the true-positive rates (sensitivity) against false-positive rates (1 -specificity) for major and combined depression of the studies reflecting that sensitivity is satisfactorily high with regards to specificity.
Discussion
It is not advisable to use universal cut-off scores, as there can be cultural differences and/or differences in how successful the adaptation of the EPDS was in a given culture, resulting in differences in at what total score the best trade-off between sensitivity and specificity can be found.
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There is a painful lack of a systematic review on the prevalence of major depressive disorder in each trimester. Trimester-specific EPDS validation studies are urgently needed in each culture instead of using non-validated cut-offs (Matthey et ), we found that there were significant differences in study design, population sampled, the timing of testing, language version of the EPDS used, and how cases were diagnosed. Overall, the studies included in this current review have provided evidence for the EPDS as a valid screening tool across different cultures, as visible from the satisfactory ROC analyses results (Area under curves (AUCs) were greater than 0.7) (Hanley and McNeil, 1982) . However, there was a wide range of sensitivity, specificity and predictive values at all cut-off points. One possible explanation for this could be differences in content validity; unfortunately, few studies provide sufficiently detailed description to assess this. The high sensitivity of the EPDS is clinically desirable for a screening instrument, as it prevents missing a depressive disorder (Flaherty et al., 1998) . High specificity combined with a high negative predictive value also fulfils the requirements for a good screening instrument. It is advisable to choose a cut-off at which the misclassification rate is not too high. Lowering the cut-off (increasing sensitivity) may make sense for established referral pathways (e.g. primary care) where the objective is to maximize detection and referring potential cases on to psychiatry.
As with any screening tool, in selecting a cut-off point, there is a trade-off between the accuracy of ruling in or out a diagnosis. At lower cut-offs, the EPDS performs considerably better overall and generally the studies suggest that it provides 'convincing evidence' (combined depression) or 'strong evidence' (major depression) by which to rule out the diagnosis.
Whilst sensitivity and specificity do not depend on prevalence, PPV and NPV do, and they showed significant variability. There are a number of explanations to be considered. Both methodologies and populations varied greatly between the studies. Samples were drawn from countries with different cultural attitudes to distress and genuine differences in prevalences. At present, when the EPDS is used in the general population, it will yield a substantial proportion of false positives, which is costly to service providers, because it generates unnecessary further assessment. Also, the EPDS will miss a considerable number of cases, similar to the majority of other screening tools. The advantage of the EPDS rests in its free availability, ease of administration and general acceptability to women, if given sympathetically. Therefore, if the above caveats are observed, it remains a useful tool in the field of perinatal mental health.
In the validation studies discussed, the identified cut-off for combined depression appears to be the most useful for screening purposes. A Norwegian validation study (Berle et al., 2003) recommended the cut-off for minor depression for screening purposes in clinical settings to detect women at risk for developing depression and to identify those who have minor depression. Identifying women with a psychiatric disorder in pregnancy is of special interest, because they are less likely to attend antenatal clinic appointments as appropriate (Zuckerman et al., 1989) , and depression, one of the commonest reasons, is relatively easy and cheap to screen for. A further argument for studying antenatal depression is the significant association of AND with PND (Robertson et al., 2004) , which with the treatment of the AND can often be prevented. 
Large confidence intervals
When estimating the sensitivity, specificity and predictive values as screening properties of an instrument, narrow confidence intervals would be desirable (Eberhard-Gran et al., 2001). Our estimates reveal variable 95% confidence intervals for the sensitivity, specificity and predictive values in most of the validation studies, which reflect the possibility of the low number of participants, the prevalence of identifiable depression cases and differences in characteristics of the EPDS version applied. It would be advisable to achieve larger samples in future validation studies.
Limitations
This systematic review has confirmed that the screening accuracy of the EPDSin diagnosing depression during pregnancy is satisfactory and that the EPDS can be recommended for use for this purpose. The heterogeneity of included studies prevented progression to meta-analysis and further statistical comparison of the EPDS across settings was not possible.
